Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pillar Point Partners

This article was originally published in The Gray Sheet

Executive Summary

Pillar Point Partners: Files patent infringement suit Sept. 9 in the U.S. District Court for Arizona against Phoenix-based Barney Dulaney Eye Center. The suit charges Dulaney with "performing laser eye surgery without a license" from the Pillar Point partnership formed in 1992 to license Summit Technology's and Visx' excimer laser technology, according to a Sept. 10 Pillar Point press release. Pillar Point files a separate suit Sept. 9 in the U.S. District Court for the District of Columbia against Washington, D.C.-based consultant William Appler for allegedly "aiding and encouraging others, including eye clinics and medical personnel, to infringe the patented technology" of the partnership. Appler has represented ophthalmic surgeons that use custom-built and reimported excimer lasers for photorefractive keratectomy and laser in situ keratomileusis (LASIK), advising the physicians on FDA policy toward the unapproved lasers...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel